From: ‘Long COVID’: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria
Patient Characteristics | N = 274 (%) |
---|---|
Age [in years] | |
≤ 35 | 92 (33.6) |
> 35–49 | 105 (38.3) |
50 and above | 77 (28.1) |
Sex | |
Male | 181 (66.1) |
Female | 93 (33.9) |
Comorbidity | |
Present | 59 (21.5) |
Absent | 215 (78.5) |
aComorbidity | n = 59 |
Diabetes (DM) | 9 (15.3) |
Hypertension (HTN) | 43 (72.9) |
Asthma | 2 (3.4) |
Peptic Ulcer Disease | 4 (6.8) |
Rheumatoid Arthritis | 3 (5.1) |
bOther | 5 (8.5) |
Initial COVID-19 severity | |
Asymptomatic | 21 (7.7) |
Mild | 139 (50.7) |
Moderate | 107 (39.0) |
Severe | 7 (2.6) |
Number of comorbid conditions | |
No comorbid condition | 215 (78.5) |
1 comorbid condition | 52 (19.0) |
2 or more comorbid conditions | 7 (2.5) |
Persistent symptoms | |
Present | 112 (40.9) |
Absent | 162 (59.1) |
Number of Persistent symptoms | |
Absent | 162 (59.1) |
1 persistent symptom | 31 (11.3) |
2 persistent symptoms | 27 (9.9) |
3 or more persistent symptoms | 54 (19.7) |
Days after discharge, median [mean; SD] | 15 days [mean: 15.6; SD ± 6.6] |